Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macrophages are specialized myeloid cells essential for innate immunity, tissue remodeling, and the maintenance of homeostasis. The macrophage cellular machinery encompasses the complex array of pattern recognition receptors, phagocytic apparatus, and intracellular signaling networks that allow the cell to respond to environmental cues (Nature Reviews Immunology, 2017). In chronic inflammatory diseases and cancer, this machinery is often co-opted or dysregulated, leading to the recruitment of tumor-associated macrophages (TAMs) that suppress anti-tumor immunity (Journal of Hematology & Oncology, 2021). Additionally, intracellular pathogens such as Mycobacterium tuberculosis and HIV-1 have evolved mechanisms to hijack the macrophage's phagosomal and metabolic machinery to facilitate their own survival and replication (Cell Host & Microbe, 2019). Therapeutic strategies targeting this machinery include the use of CSF1R inhibitors to reduce macrophage infiltration and CD47-SIRPα axis blockers to restore phagocytic activity against malignant cells (Frontiers in Immunology, 2020). Despite the therapeutic potential, targeting the macrophage machinery presents significant challenges, including the risk of systemic inflammation and impaired wound healing.
Therapeutic modulation involves inhibiting macrophage recruitment (e.g., via CSF1R or CCR2 inhibition), enhancing phagocytic activity by blocking 'don't eat me' signals (e.g., CD47-SIRPα axis), or reprogramming macrophages from an immunosuppressive M2-like state to a pro-inflammatory M1-like state using TLR agonists or cytokines.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage cellular machinery (None).